医学
Blinatumoab公司
白血病
慢性淋巴细胞白血病
急性淋巴细胞白血病
肿瘤科
淋巴细胞白血病
内科学
作者
Jessica Turner,Susan Schneider
标识
DOI:10.1188/16.cjon.165-168
摘要
Attentive symptom monitoring and management are crucial. Individuals who achieve remission from blinatumomab can then be considered for stem cell transplantation and a chance for cure.
科研通智能强力驱动
Strongly Powered by AbleSci AI